Twenty-nine patients, aged 11 -79 years (mean, 50 years), with Lyme neuroborreliosis, facial nerve palsy, and meningitis were treated with oral doxycycline (daily dose, 200 -400 mg) for 9 -17 days in a prospective, nonrandomized study. Facial paresis was bilateral in eight (28%) of the 29 patients. Twenty-six patients (90%) recovered without sequelae within 6 months, while three of the patients with bilateral facial palsy at admission had remaining paresis at follow-up. In five patients, contralateral facial paresis developed 1 -12 days after initiation of therapy, and two patients were retreated with antibiotics. Posttreatment examinations of cerebrospinal fluid showed a marked decrease of inflammatory cells and protein concentrations compared with pretreatment levels in all followed up patients. The favorable clinical outcome agrees with findings of other reports on intravenous antibiotic therapy for Lyme disease -associated meningitis with facial palsy. Our conclusion is that oral doxycycline is an effective and convenient therapy for Lyme disease -associated facial palsy.
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Cranial neuropathy is the most frequent objective neurologiremains unclear, as reflected by the wide range of reported treatment recommendations regarding first-line drugs, route of cal sign in Lyme neuroborreliosis and has been found in 47% -82% of patients with early neurological involvement [1] . Alantibiotic administration, and duration of antiinfective therapy. Doxycycline has been considered an alternative oral treatthough Borrelia burgdorferi sensu lato may affect most cranial nerves, facial nerve paresis is the most common manifestation ment of Lyme neuroborreliosis because of the pharmacokinetic properties of this lipophilic agent [11, 12] . The oral absorption of infection. Unilateral or bilateral facial palsy has been described in 72% -92% of patients with cranial nerve affection is considered to be 95% [13] , and it has been shown that plasma concentrations are equivalent when doxycycline is given by the [1, 2] . In previous Scandinavian studies of patients with Lyme neuroborreliosis, facial palsy was seen in 35% -51% of the oral compared with the parenteral route [14] . The doxycycline concentration in CSF has been found to exceed the highest cases [3, 4] . Lyme disease -associated facial weakness is often rapid in onset and is frequently accompanied by painful menreported MIC 90 for B. burgdorferi sensu lato when patients are treated by the oral route [11] , and several studies have shown ingoradiculoneuritis, earlier described as Garin-BujadouxBannwarth's syndrome [1] . Facial palsy in Lyme disease has that good clinical responses occur when orally or intravenously administered doxycycline is used as treatment of Lyme neurooften been viewed as peripheral neuropathy, although most patients have CSF abnormalities with lymphocytic pleocytosis borreliosis [6, 10, 15] . In this nonrandomized, prospective trial, we studied the effiand an increased number of plasma cells, increased CSF protein concentrations indicating blood-CSF barrier damage, intrathecacy of oral doxycycline therapy for patients with Lyme disease -associated meningitis and facial palsy. cal Ig production, and increased levels of a CSF glial protein marker (glial fibrillary acidic protein) [5] . These findings imply that the brain parenchyma is likely to be involved even in early Patients and Methods Lyme neuroborreliosis.
A few major prospective, randomized trials of antibiotic
Patients and Inclusion and Exclusion Criteria
therapy for Lyme neuroborreliosis in adult patients with facial palsy have been reported [6 -10] . However, the optimal antiOne hundred twenty consecutive patients with Lyme neuromicrobial therapy for Lyme disease -associated facial palsy borreliosis were admitted to the Department of Infectious Diseases, Sahlgrenska University Hospital/Ö stra, Göteborg, Sweden, between 1988 and 1996; these patients were included in the Lyme neuroborreliosis study at the department. Unilateral
Exclusion critera for the doxycyline treatment study were between outcome and CSF findings, pretreatment duration, and age were made with the Mann-Whitney U test. age younger than 8 years, pregnancy, previous allergic reactions to doxycycline, and intravenous b-lactam therapy within 2 weeks before admission. Four of the 38 patients with facial Results palsy (three children [mean age, 6 years] and one adult) were not included in the doxycycline treatment study; these patients
Clinical Findings
were treated with intravenous penicillin G.
Pretreatment characteristics, treatment data, and clinical outThirty-four of the adult patients with facial palsy were treated come for the doxycycline-treated patients are shown in table with oral doxycycline. Three patients with facial nerve palsy 1. A previous tick bite was recalled by 11 patients (38%), and and positive borrelia serologies had normal results of CSF erythema migrans was found in 10 (34%). Most patients (86%) examinations and were excluded from the study. Two patients presented with painful meningoradiculoneuritis or a distinct were lost to follow-up.
feeling of discomfort followed by development of facial neuThus, a total of 29 patients (11 women and 18 men; mean ropathy several days later, consistent with the classical Garinage, 50 years) with Lyme disease -associated facial palsy and Bujadoux-Bannwarth's syndrome. Three patients were admitmeningitis who were treated with oral doxycycline were evaluted to the hospital with general malaise, low-grade fever, and ated for efficacy of the treatment (table 1) . In cases with comheadache in addition to the facial palsy, while one patient plete facial paralysis, an otoneurological examination was per-(with bilateral facial paresis) experienced only slight general formed at admission. None of the patients had diabetes or any discomfort and no other neurological signs or symptoms. other serious concomitant disorders. There was no history of Bilateral palsy was found in eight (28%) of the 29 patients recurrent facial palsy. All but two of the patients were seen by with facial nerve paresis. Five of these patients developed conone of the two authors.
tralateral facial palsy within 1 -12 days (mean, 6.0 days) after The patients were followed up at the Department of Infecthe start of antibiotic treatment. In two other patients treated for tious Diseases for 5 -108 months (median, 30 months). SamLyme disease -associated meningoradiculitis, unilateral facial ples for borrelia serology, blood tests, and CSF analyses were paresis occurred during antimicrobial therapy. The other neuroobtained at enrollment and 6 -8 weeks thereafter. Follow-up logical manifestations, including radiculitic pain, resolved or CSF examinations were approved by the ethics committee at decreased in intensity in all patients during antibiotic treatment. Göteborg University, Göteborg, Sweden.
Neither pretreatment disease duration nor patient age was found to be associated with bilateral facial paresis.
CSF and Serum Samples

CSF Changes
CSF samples from all patients before the start of antibiotic therapy were analyzed. Twenty-six (90%) of the 29 patients CSF cell counts before and after treatment are shown in underwent second lumbar puncture 33 -102 days (median, /L during therapy. The mean bacterial cultures, determination of protein and glucose conpretreatment CSF protein concentration was 1,649 mg/L, and centrations and albumin CSF/serum ratio, and isoelectric the mean posttreatment level was 536 mg/L. CSF cytology focusing.
before treatment showed characteristic abnormalities with reacSerum and CSF specimens were analyzed with a commertive lymphocytic pleocytosis and an increased number of cial ELISA for IgG and IgM antibodies to purified native plasma cells in all patients. Three or more oligoclonal Ig bands Borrelia burgdorferi sensu lato flagellum (Dako, Glostrup, were noted by CSF protein electrophoresis and isoelectric foDenmark). The cutoff levels for corrected absorbance and cusing as a sign of intrathecal antibody production in 27 (93%) the intraassay and interassay variations were in accordance of the 29 patients. CSF glucose levels were normal in all pawith the manufacturer's recommendations. Specific western tients. Neither pretreatment CSF cell counts nor pretreatment blotting (immunoblotting) or PCR assays were not done.
CSF protein concentrations were associated with the occurWassermann and VDRL (Venereal Disease Research Laborence of bilateral palsy, although the two highest CSF protein ratory) tests were performed on serum samples from all values were found in patients with facial diplegia (patients 25 patients. and 27).
Statistical Methods Borrelia and Syphilis Serology
All patients had positive borrelia antibody tests in serum, The NOTE. Mean duration between first and second lumbar punctures was 43.5 days. 1 Å no facial paresis at 2-month follow-up; 2 Å no signs of facial palsy within 6 months; 3 Å sequelae.
* Duration before therapy refers to neurological symptoms.
borrelia serology in serum, and 25 (86%) had a CSF test posiAnother patient developed transient hemiparesis during treatment, possibly an infection-triggered vascular ischemia. This tive for antibody to Borrelia. All but one patient had negative Wassermann tests. The confirming Treponena pallidum hemagpatient recovered without any sequelae. Less than one-half of the patients complained of minor gastrointestinal irritation. No glutination assay and fluorescent treponemal antibody absorption test for IgM and IgG were negative for this patient.
photosensitivity reactions were reported.
Retreatment Duration of Therapy and Adverse Effects
The duration of treatment with oral doxycycline was 9 -17 Two patients were retreated because of progression of facial palsy during doxycycline treatment. One of the patients, who days (mean, 10.8 days). The doxycycline dosage was 200 mg twice daily for 28 of 29 patients and 100 mg twice daily for had complete unilateral facial palsy at admission, developed contralateral paresis 12 days after the start of therapy and was one 11-year-old child. One patient experienced a JarischHerxheimer reaction after the first dose of oral doxycycline.
given another course of oral doxycycline for 13 days. Another / 9c63$$mr04 02-22-99 13:29:43 cida UC: CID patient (no. 10), who had meningitis and excruciating radiculiough epidemiological investigations of B. burgdorferi sensu lato in ticks on migrating birds in Scandinavia showed that tic pain but no signs of paresis at the start of treatment, developed unilateral facial palsy on the ninth day of antibiotic therthe subspecies Borrelia garinii was the most prevalent of the Borrelia genospecies [24] . Among European B. burgdorferi apy. A second spinal tap on the same day showed a decrease in the CSF lymphocyte count from 436 to 93 1 10 6 /L in parallel strains isolated in clinical studies, B. garinii has also been the most common subspecies found in CSF samples from patients with pronounced relief of the severe pain. He was treated with intravenous cefotaxime for 7 days. Both retreated patients rewith Lyme neuroborreliosis [25] , implying that B. garinii was the probable etiology of most cases in this trial. covered without sequelae within 8 weeks.
Of all clinical manifestations of Lyme neuroborreliosis, facial paresis is more easily objectively evaluated than other Clinical Outcome symptoms, such as radiculitic pain, sensory deficits, or encephalopathy. However, there are specific difficulties in assessing Six months after treatment, 90% of the patients had no residual signs of Lyme disease -associated facial palsy (table 1) .
the efficacy of antibiotic therapy for the acute phase of Lyme disease -associated facial paresis. First, although antibiotic Three patients (10%) had remaining facial palsy with contracture at follow-up after 24 months, including one with only treatment appears to relieve neurological symptoms and contribute to the resolution of CSF inflammation, cranial neuropaslight unilateral residual paresis. The clinical finding of facial diplegia was significantly correlated to residual symptoms thy may still progress, with development of contralateral palsy up to a few days after the initial facial paresis (possibly due (P Å .003). None of these three patients needed occlusive glasses for the eyes after the initial months. The pretreatment to an inflammatory response and the limited space in which the facial nerve is situated) [4] . Second, spontaneous recovery durations of facial palsy did not differ between the patients with and without sequelae. Pretreatment disease duration, CSF often occurs even without antibiotic therapy. Among adult patients presenting with peripheral idiopathic facial palsy (Bell's cell count and protein level, and patient age were not associated with clinical sequelae. palsy), the recovery rate reported in five studies was 72% -83% [26] . The outcome of facial weakness in children seems Additional neurological symptoms were found in 12 of the patients at the follow-up examination. Eight patients (28%) to be better than that of facial weakness in adults [22] . In a well-defined Danish group of 95 patients with Lyme experienced temporary subjective manifestations of paresthesias and hypoesthesias during the first months after therapy, neuroborreliosis and facial palsy, of whom most were treated with intravenous penicillin G, 15% and 3% were found to have while four patients (14%) had symptoms of fatigue and concentration impairment at a follow-up 6 months later. Objective slight and severe posttreatment sequelae after unilateral palsy, respectively [4]. The corresponding rates among patients with sequelae were found only in one patient at a follow-up 6 months later (slight supranuclear arm paresis and partial facial diplegia) bilateral palsy were 37% and 7%, respectively. The number of patients with severe sequelae agrees with the result of the in addition to the two other patients with residual signs of facial palsy. present study. Two patients were retreated because of progression of the symptoms at the end of the first antibiotic course. However, Discussion CSF analysis after the first treatment period for one of the patients showed a marked decrease in cell count and protein In this nonrandomized, prospective treatment study during an 8-year period, all patients older than 10 years of age at concentration as a sign of antimicrobial efficacy. The other patient was retreated with oral doxycyline. In all patients, the Department of Infectious Diseases, Sahlgrenska University Hospital/Ö stra, who had Lyme neuroborreliosis -associated fathe CSF cell count was either normalized or decreased to õ30% of the initial value in a mean of 55.6 days after cial paresis and meningitis were treated with oral doxycycline if the inclusion criteria were fulfilled. Oral doxycycline treatment. CSF cell counts and protein concentrations are valuable (200 mg twice daily) has been the recommended treatment of Lyme neuroborreliosis in adults at this department since 1987.
means of assessing disease activity and the efficacy of antimicrobial treatment of Lyme neuroborreliosis. In another EuroIn addition to clinical outcome, CSF cell counts and protein levels before and after treatment were analyzed. We found pean study, improvement of these CSF parameters was shown to reflect clinical recovery in 37 patients treated with ceftriaxthat oral doxycyline was effective and convenient treatment of Lyme disease -associated facial paresis.
one intravenously for early and late Lyme neuroborreliosis [27] . Seventeen of these patients had facial palsy. The CSF B. burgdorferi has been regarded as the etiologic agent of peripheral facial palsy of otherwise unknown origin in 11% -findings for our patients treated with doxycycline were in accordance with those for the ceftriaxone-treated patients. 20% of adult patients in Sweden [17 -20] . In children, 33% -64% of the cases of facial paresis are caused by borreliosis Oral treatment has several advantages. It reduces the number of visits to hospitals or outpatient clinics, and it is more cost- [21 -23] . Culture or characterization of the genospecies of the Borrelia spirochete was not done in this study. However, thoreffective than parenteral antimicrobial administration. The use / 9c63$$mr04 02-22-99 13:29:43 cida UC: CID
